9:17 AM
 | 
Aug 09, 2018
 |  BC Extra  |  Financial News

Novo Holdings leads Therachon's $60M round

Rare disease company Therachon AG (Basel, Switzerland) said it completed a $60 million mezzanine financing led by new investor Novo Holdings.

Fellow new investors Cowen Healthcare Investments, Pfizer Ventures and funds managed by Tekla Capital Management participated, as did existing investors Versant Ventures,...

Read the full 191 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >